Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S John Weroha

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Endocrinology and Metabolism Clinics of North America|June 12, 2012
The insulin-like growth factor system in cancerS John Weroha, Paul Haluska
Journal of Mammary Gland Biology and Neoplasia|November 22, 2008
IGF-1 receptor inhibitors in clinical trials--early lessonsS John Weroha, Paul Haluska
Medical Oncology (Northwood, London, England)|June 18, 2009
Treatment of hormone-refractory prostate cancer, HRPC, remains challengingS John Weroha, J Fernando Quevedo
JAMA|July 21, 2025
Ovarian Cancer: A ReviewGiuseppe Caruso, S John Weroha, William Cliby
Gynecologic Oncology Reports|February 3, 2022
Non-gestational choriocarcinoma with hyperprogression on pembrolizumab: A case report and review of the literatureNazanin Yeganeh Kazemi, Carrie Langstraat, S John Weroha
Carcinogenesis|November 29, 2005
Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI ratsS John Weroha, Sara Antonia Li, Ossama Tawfik, et al.
Oncotarget|November 22, 2017
Investigation of factors affecting the efficacy of 3C23K, a human monoclonal antibody targeting MISIIRSarah E Gill, Qing Zhang, Gary L Keeney, et al.
Hormones & Cancer|July 16, 2011
Specific overexpression of cyclin E·CDK2 in early preinvasive and primary breast tumors in female ACI rats induced by estrogenS John Weroha, Wilma L Lingle, Yan Hong, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|May 4, 2012
Quantifying insulin receptor isoform expression in FFPE breast tumorsSean C Harrington, S John Weroha, Carol Reynolds, et al.
Oncogene|September 15, 2020
Targeting an autocrine IL-6-SPINK1 signaling axis to suppress metastatic spread in ovarian clear cell carcinomaChristine Mehner, Erin Miller, Alexandra Hockla, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Endocrinology and Metabolism Clinics of North America|June 12, 2012
The insulin-like growth factor system in cancerS John Weroha, Paul Haluska
Journal of Mammary Gland Biology and Neoplasia|November 22, 2008
IGF-1 receptor inhibitors in clinical trials--early lessonsS John Weroha, Paul Haluska
Medical Oncology (Northwood, London, England)|June 18, 2009
Treatment of hormone-refractory prostate cancer, HRPC, remains challengingS John Weroha, J Fernando Quevedo
JAMA|July 21, 2025
Ovarian Cancer: A ReviewGiuseppe Caruso, S John Weroha, William Cliby
Gynecologic Oncology Reports|February 3, 2022
Non-gestational choriocarcinoma with hyperprogression on pembrolizumab: A case report and review of the literatureNazanin Yeganeh Kazemi, Carrie Langstraat, S John Weroha
Carcinogenesis|November 29, 2005
Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI ratsS John Weroha, Sara Antonia Li, Ossama Tawfik, et al.
Oncotarget|November 22, 2017
Investigation of factors affecting the efficacy of 3C23K, a human monoclonal antibody targeting MISIIRSarah E Gill, Qing Zhang, Gary L Keeney, et al.
Hormones & Cancer|July 16, 2011
Specific overexpression of cyclin E·CDK2 in early preinvasive and primary breast tumors in female ACI rats induced by estrogenS John Weroha, Wilma L Lingle, Yan Hong, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|May 4, 2012
Quantifying insulin receptor isoform expression in FFPE breast tumorsSean C Harrington, S John Weroha, Carol Reynolds, et al.
Oncogene|September 15, 2020
Targeting an autocrine IL-6-SPINK1 signaling axis to suppress metastatic spread in ovarian clear cell carcinomaChristine Mehner, Erin Miller, Alexandra Hockla, et al.
Pageof 9